HMGB1 in development and diseases of the central nervous system.
about
Microglia centered pathogenesis in ALS: insights in cell interconnectivityStress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory primingMénage à Trois in stress: DAMPs, redox and autophagyStress-induced neuroinflammatory priming: A liability factor in the etiology of psychiatric disordersAmyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's diseaseAlcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation.HMGB1 in health and disease.Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress.Impact of Tobacco Smoking and Type-2 Diabetes Mellitus on Public Health: A Cerebrovascular Perspective.The effect of glycomimetic functionalized collagen on peripheral nerve repair.Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury.HMGB1 protein does not mediate the inflammatory response in spontaneous spinal cord regeneration: a hint for CNS regeneration.Adolescent binge drinking increases expression of the danger signal receptor agonist HMGB1 and Toll-like receptors in the adult prefrontal cortex.Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell ModelHMGB1 in hormone-related cancer: a potential therapeutic target.Designing drugs that encourage spinal cord injury healing.Immunoadolescence: Neuroimmune development and adolescent behavior.Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders.Sterile Neuroinflammation and Strategies for Therapeutic InterventionBlood neuron-derived exosomes as biomarkers of cognitive impairment in HIV.HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to NeurodegenerationDoes enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.HMGB1 contributes to regeneration after spinal cord injury in adult zebrafish.In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizinGlycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice.Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner.sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer's-Related Pathology via HMGB1 Inhibition.Serum high-mobility group box 1 protein correlates with cognitive decline after gastrointestinal surgery.Cerebrospinal fluid high mobility group box 1 is associated with neuronal death in subarachnoid hemorrhage.Extracellular HMGB1 Modulates Glutamate Metabolism Associated with Kainic Acid-Induced Epilepsy-Like Hyperactivity in Primary Rat Neural Cells.Brain tumour cells interconnect to a functional and resistant network.Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein.Anti-high mobility group box 1 antibody suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury.A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes.Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease.
P2860
Q27009559-2D73589C-7013-4433-8283-66E9DD4580DAQ27013816-173C3A01-06F3-471C-95F5-41596D39677AQ27023542-40AD66DA-5557-4AC6-995F-DBA44FF0B376Q28071417-581BCE9F-BD95-4FEE-8012-B33AD62797EEQ28384947-0A6BEC60-85EA-4E10-BEDD-DB09CFCA5A9AQ30389531-4C5AC5AF-BF96-4BCE-886F-8C7C310268D0Q34622835-91591C47-0E3B-4001-8872-F7C7EFEB2255Q35179057-E826F22F-8FDC-4ADC-8D03-321DEC954A6BQ36455589-50721F9C-B0FF-4F63-A12F-9ED406F4135AQ36758232-6A6C94D3-91BE-4556-95D1-1ADA5842BAA0Q36764867-B6C3F420-C873-4E4D-8CFC-4D45F49205D1Q36947789-6923CC77-A670-439A-A4BE-ED130C9A09CDQ37087906-8A874D5B-4AB8-42E9-9595-ED6FDE0FA821Q37179174-13A647A8-B2E9-4A8D-838A-5C91C6044414Q37199557-53DD8C7A-E01F-4F93-BC6D-8C27A1C1636FQ37614664-FF475053-73F9-47C0-BBB6-D437B99A84ACQ38203471-AF05CD5A-7D4A-4C34-88AA-A9EC85BCF52DQ38234093-67C291DA-E7EC-45E8-A4C1-8D91E305DBE9Q38853365-9A65BDC4-C5DD-4D84-BCD8-2BB8374B1008Q38895967-50C9D36C-DBA6-4306-BB81-D6CAC933CACCQ39105980-3D354576-B5DB-4C4B-9B40-9916D2B42536Q40141673-EFA328C7-7691-49C1-8D0F-A7723C62E14CQ40322637-14B4D840-8D81-4BC7-B45A-552942388296Q41511974-C07FB02A-29E5-4177-9D51-A94B1DE53EA4Q41613567-06B58943-0189-4593-BBE3-E344EDDCD9F8Q42197380-13C7AD8D-0D37-48B1-9C22-EF055279E12AQ42443984-501EB5BC-955A-495F-9A55-F747B67D3593Q42786914-99A9DC9F-854E-4173-8969-54BF14D51EA3Q46088882-5617AF1D-6C1B-4EB2-88DA-8DD3484CE70FQ47117171-48AA4180-3A71-4FFD-A751-D0DD3848DB7EQ47133236-9362F84A-16C8-41F4-9AF6-141CC65FF413Q47241431-40DC4976-4620-47A4-9D52-524C3D041CD5Q47880904-2BB3908F-9675-465F-BF98-641418AB5D54Q48942808-89D52A8B-B789-43BB-9D40-408D4F45941DQ51129095-57D80E0D-E662-4AEF-B31D-52A161717AE4Q52147171-13A5724A-46A8-4F2A-BE68-EBF16B169DC6Q52313052-7480CCA0-31CB-4BEA-BA1E-CEDA3A36078DQ55040179-1F6C017F-8830-4BAB-AA3A-66B6293EEE15Q55057831-1744D507-A77C-4BCC-9AC3-58D76AB5D70AQ55226753-72ABDA6C-62FE-4D71-832C-CDDC334E3675
P2860
HMGB1 in development and diseases of the central nervous system.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HMGB1 in development and diseases of the central nervous system.
@en
type
label
HMGB1 in development and diseases of the central nervous system.
@en
prefLabel
HMGB1 in development and diseases of the central nervous system.
@en
P2860
P1476
HMGB1 in development and diseases of the central nervous system.
@en
P2093
Yan-Qin Shen
P2860
P2888
P304
P356
10.1007/S12035-012-8264-Y
P577
2012-05-13T00:00:00Z
P6179
1012543619